These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9329900)

  • 1. Pustular eruption in a malaria patient treated with chloroquine.
    Wilairatana P; Looareesuwan S; Riganti M; Teja-Isavadharm P; Keeratithakul D; Eickmeyer S; Walsh DS
    Int J Dermatol; 1997 Aug; 36(8):634-5. PubMed ID: 9329900
    [No Abstract]   [Full Text] [Related]  

  • 2. Pustular eruption in a malaria patient treated with chloroquine.
    Wilairatana P; Looareesuwan S; Riganti M; Teja-Isavadharm P; Keeratithakul D; Eickmeyer S; Walsh DS
    Int J Dermatol; 1998 Sep; 37(9):713-4. PubMed ID: 9762829
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequency of pruritus in Plasmodium vivax malaria patients treated with chloroquine in Thailand.
    Bussaratid V; Walsh DS; Wilairatana P; Krudsood S; Silachamroon U; Looareesuwan S
    Trop Doct; 2000 Oct; 30(4):211-4. PubMed ID: 11075653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute generalized exanthematous pustulosis precipitated by hydroxychloroquine.
    Evans CC; Bergstresser PR
    J Am Acad Dermatol; 2004 Apr; 50(4):650-1. PubMed ID: 15034525
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.
    Krudsood S; Tangpukdee N; Muangnoicharoen S; Thanachartwet V; Luplertlop N; Srivilairit S; Wilairatana P; Kano S; Ringwald P; Looareesuwan S
    Korean J Parasitol; 2007 Jun; 45(2):111-4. PubMed ID: 17570973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity related to chloroquine treatment of resistant vivax malaria.
    Davis TM; Syed DA; Ilett KF; Barrett PH
    Ann Pharmacother; 2003 Apr; 37(4):526-9. PubMed ID: 12659609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital malaria due to chloroquine-resistant Plasmodium vivax: a case report.
    Mohan K; Maithani MM
    J Trop Pediatr; 2010 Dec; 56(6):454-5. PubMed ID: 20388657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe mucocutaneous necrotizing vasculitis associated with the combination of chloroquine and proguanil.
    Luong MS; Bessis D; Raison-Peyron N; Pinzani V; Guilhou JJ; Guillot B
    Acta Derm Venereol; 2003; 83(2):141. PubMed ID: 12735648
    [No Abstract]   [Full Text] [Related]  

  • 9. [Research progress on Plasmodium vivax chloroquine resistance].
    Li JY; Li Q; Fang Q
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2014 Jun; 26(3):326-31. PubMed ID: 25345166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors associated to pruritus in Plasmodium vivax patients using chloroquine in the Brazilian Amazon.
    Ballut PC; Siqueira AM; Orlando AC; Alexandre MA; Alecrim MG; Lacerda MV
    Acta Trop; 2013 Dec; 128(3):504-8. PubMed ID: 23906614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium vivax clinically resistant to chloroquine in Colombia.
    Soto J; Toledo J; Gutierrez P; Luzz M; Llinas N; Cedeño N; Dunne M; Berman J
    Am J Trop Med Hyg; 2001 Aug; 65(2):90-3. PubMed ID: 11508397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study.
    Valecha N; Savargaonkar D; Srivastava B; Rao BH; Tripathi SK; Gogtay N; Kochar SK; Kumar NB; Rajadhyaksha GC; Lakhani JD; Solanki BB; Jalali RK; Arora S; Roy A; Saha N; Iyer SS; Sharma P; Anvikar AR
    Malar J; 2016 Jan; 15():42. PubMed ID: 26818020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistant Plasmodium vivax malaria.
    Whitby M
    J Antimicrob Chemother; 1997 Dec; 40(6):749-52. PubMed ID: 9462425
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute generalized exanthematous pustulosis due to the combination of chloroquine and proguanil.
    Janier M; Froidevaux D; Lons-Danic D; Daniel F
    Dermatology; 1998; 196(2):271. PubMed ID: 9568425
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral artesunate for neonatal malaria.
    Avabratha KS; Chettiyar LA; John NP
    J Trop Pediatr; 2010 Dec; 56(6):452-3. PubMed ID: 20144934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vivax malaria resistant to chloroquine: case reports from Bombay.
    Garg M; Gopinathan N; Bodhe P; Kshirsagar NA
    Trans R Soc Trop Med Hyg; 1995; 89(6):656-7. PubMed ID: 8594687
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasmodium vivax malaria presenting as the nephrotic syndrome in an infant.
    David J; Shanbag P; More V
    Trop Doct; 2009 Apr; 39(2):127-8. PubMed ID: 19299308
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasmodium vivax malaria presenting with skin rash--a case report.
    Zaki SA; Shanbag P
    J Vector Borne Dis; 2011 Dec; 48(4):245-6. PubMed ID: 22297289
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Guragae zone southern Central Ethiopia.
    Shumbej T; Jemal A; Worku A; Bekele F; Weldesenbet H
    BMC Infect Dis; 2019 May; 19(1):413. PubMed ID: 31088384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloroquine resistance in Plasmodium vivax.
    Baird JK
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4075-83. PubMed ID: 15504824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.